Cancer: it's time to change the sign

Downar, James
October 2010
CMAJ: Canadian Medical Association Journal;10/5/2010, Vol. 182 Issue 14, p1588
Academic Journal
The article offers the author's views which suggest to change slogans, captions and signs related to the campaign the dreadful disease, cancer. The author stresses that it is unrealistic to claim the successes and progress on studies conducted for the treatment of cancer but little has been noted on the assumption of treatments which have not yet been discovered. Moreover, the author meant that cancer could never be cured but to reflect on the reality that treatment is yet to be found.


Related Articles

  • CANCER PATIENTS GET THE WORD OUT. Horn, Clare; Althoff, Susanne; Nachatelo, Melissa // Natural Health;Dec2001, Vol. 31 Issue 9, p19 

    Reports the efforts made by grass-roots group of cancer patients and their families in advocating the nontoxic cancer treatment, 714X in the United States. Importance of the ordinary people in applying pressure on the cancer establishments; Developer of the treatment; Testimonies of cancer...

  • Help from Hume reconciling professionalism and managed care. Kopelman, Loretta M.; Kopelman, L M // Journal of Medicine & Philosophy;Aug99, Vol. 24 Issue 4, p396 

    Health care systems are widely criticized for limiting doctors' roles as patient-advocates. Yet unrestricted advocacy can be unfairly partial, costly, and prejudicial. This essay considers three solutions to the problem of how to reconcile the demands of a just health care system for all...

  • Company Profile for Fight Colorectal Cancer.  // Biomedical Market Newsletter;5/18/2012, Vol. 21, p1 

    The article informs that a Fight Colorectal Cancer, an advocacy organization, has demanded better medical policies to cure colon and rectal cancer.

  • A survey of the perspectives of patients who are seriously ill regarding end-of-life decisions in some medical institutions of Korea, China and Japan. Ivo, Kwon; Younsuck, Koh; Ho, Yun Young; Sang-Yeon, Suh; Seog, Heo Dae; Hyunah, Bae; Kenji, Hattori; Xiaomei, Zhai // Journal of Medical Ethics;May2012, Vol. 38 Issue 5, p310 

    Purpose The debate about the end-of-life care decision is becoming a serious ethical and legal concern in the Far-Eastern countries of Korea, China and Japan. However, the issues regarding end-of-life care will reflect the cultural background, current medical practices and socioeconomic...

  • Substitute decision making in medicine: comparative analysis of the ethico-legal discourse in England and Germany. Ralf Jox; Sabine Michalowski; Jorn Lorenz; Jan Schildmann // Medicine, Health Care & Philosophy;Jun2008, Vol. 11 Issue 2, p153 

    Abstract  Health care decision making for patients without decisional capacity is ethically and legally challenging. Advance directives (living wills) have proved to be of limited usefulness in clinical practice. Therefore, academic attention should focus more on substitute decision making...

  • Patient Advocacy: Roles for Nurses and Leaders. Smith, Alison P. // Nursing Economic$;Mar/Apr2004, Vol. 22 Issue 2, p88 

    Focuses on the ethical perspective of patient advocacy in the U.S. Implementation of a patient safety program by hospitals; Description of nursing role in the definition of patient advocacy; Details on the moral values system of the nursing profession.

  • About the Responsibility and Obligation to Protect Patient Privacy. Ying-Kuan Wang // Tzu Chi Nursing Journal;Dec2013, Vol. 12 Issue 6, p12 

    No abstract available.

  • AVOIDING QUALITY FRAUD. Gosfield, Alice G.; Reinerstein, James L. // Trustee;Sep2008, Vol. 61 Issue 8, p12 

    This article examines the liability of a hospital's leadership for quality fraud and highlights what enforcers have said about trustee responsibility for these issues. Hospitals have been sanctioned for gross quality failures. In 2008, quality fraud enforcers have become more aggressive by...

  • Educating for Personalized Medicine: A Perspective From Oncology. Parkinson, D. R.; Ziegler, J. // Clinical Pharmacology & Therapeutics;Jul2009, Vol. 86 Issue 1, p23 

    The personalized-medicine concept represents the future of oncology medicine. New genomics technologies will characterize patients biologically in ways that will drive more efficient and effective cancer treatment. Yet the introduction of these technologies is disruptive to current practices in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics